Michael Robert Martin - 07 Nov 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Business Officer
Signature: /s/ Michael Robert Martin
Issuer symbol: AUPH
Transactions as of: 07 Nov 2022
Net transactions value: +$154,800
Form type: 4
Filing time: 09 Nov 2022, 15:05:21 UTC
Previous filing: 04 Mar 2022
Next filing: 06 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Purchase	$154,800	+30,000	+50%	$5.16	89,512	07 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.98 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.98 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.